Conservative Versus Aggressive Revascularization in Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance Alone (SMART-CASE)
|ClinicalTrials.gov Identifier: NCT00743899|
Recruitment Status : Unknown
Verified December 2013 by Hyeon-Cheol Gwon, Samsung Medical Center.
Recruitment status was: Active, not recruiting
First Posted : August 29, 2008
Last Update Posted : December 10, 2013
Samsung Medical Center
Information provided by (Responsible Party):
Hyeon-Cheol Gwon, Samsung Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||June 2013|
|Estimated Study Completion Date :||June 2016|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Hahn JY, Choi SH, Jeong JO, Song YB, Choi JH, Park YH, Chun WJ, Oh JH, Cho DK, Lim SH, Choi YJ, Im ES, Won KH, Lee SY, Kim SW, Gwon HC. Conservative versus aggressive treatment strategy with angiographic guidance alone in patients with intermediate coronary lesions: The SMART-CASE randomized, non-inferiority trial. Int J Cardiol. 2017 Aug 1;240:114-119. doi: 10.1016/j.ijcard.2017.03.075. Epub 2017 Mar 18.